FinTech

The latest news

Michael Selig, Chair of the Commodity Futures Trading Commission, during the expansion of federal oversight over prediction markets and event contracts.

Trump Backs CFTC Authority Over Prediction Markets

Read more
Klarna branding displayed at the New York Stock Exchange during the company’s IPO as investors react to Klarna quarterly earnings and Klarna 1 billion Q1 revenue growth milestone in fintech and digital payments markets

Klarna Posts $1B Quarter as Fintech Maturity Gains Pace

Read more
Robinhood Q1 2026 earnings report showing $1.07 billion revenue, platform growth to $307 billion assets, Gold subscribers increase and expansion strategy amid crypto revenue decline

Robinhood Posts $1.07B Revenue as Platform Expands

Read more
Scott Bessent Trump Accounts program US Treasury as Trump Accounts savings system launches with BNY Mellon and Robinhood for newborn savings accounts policy and public private capital model

BNY Mellon and Robinhood to Power Trump Accounts Program

Read more
Revolut profit growth as global banking expansion accelerates, highlighting fintech profitability and digital banking scale

Revolut Posts £1.7B Profit as Global Banking Push Begins

Read more
Revolut headquarters in London following the approval of the Revolut UK banking licence by regulators.

Revolut Becomes a Full UK Bank After Five-Year Push

Read more
Robinhood CEO Vlad Tenev rings the opening bell at the New York Stock Exchange as Robinhood Ventures Fund debuts on the NYSE offering retail investors access to private technology companies.

Robinhood Ventures Opens Private Markets to Retail Investors

Read more
Affirm profitability rises as BNPL transaction volumes accelerate, reflecting stronger unit economics and sustained earnings in consumer finance.

Affirm Achieves Profitability as BNPL Volumes Accelerate

Read more

HealthTech News

View All
Hims & Hers Health Q2 2026 earnings and financial results, showing the company amid record revenue growth, international expansion following the Eucalyptus acquisition, weight loss and GLP-1 business changes, and mounting legal and regulatory risk from the FTC privacy lawsuit.

Hims & Hers Posts Record Revenue Amid Mounting Legal Risk

Read more
Scientist holding a laboratory test tube during pharmaceutical research at Novo Nordisk, illustrating Ziltivekimab, ZEUS trial, IL-6 inhibitor research, cardiovascular inflammation therapy, heart disease treatment and clinical drug development.

Novo Nordisk's Ziltivekimab Fails Pivotal Heart Trial

Read more
Eli Lilly Q1 2026 results reflecting tirzepatide sales surge, Mounjaro and Zepbound growth, and expanding GLP-1 drug market demand

Eli Lilly Posts 56% Revenue Surge as Incretin Empire Expands

Read more